AstraZeneca PLC
AZNAstraZeneca plc (/ˌæstrəˈzɛnəkə/) (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Drugs in Pipeline
498
Phase 3 Programs
282
Upcoming Catalysts
46
Next Catalyst
Jun 2, 2026
3dMarket Overview
Stock performance and key metrics
53 upcoming, 9 past
Placebo Phase 3 Results Expected
Primary completion for Placebo trial (NCT04550260) in Esophageal Squamous Cell Carcinoma
Double win in Phase III trials
SourceDurvalumab Phase 3 Est. Readout
Primary completion for Durvalumab trial (NCT04550260) in Esophageal Squamous Cell Carcinoma
SourceAZD7798 Phase 2 Est. Readout
Primary completion for AZD7798 trial (NCT06450197) in Moderate to Severe Crohn's Disease
Source50 more catalysts beyond 14 days
Start a 48h free trial to see all upcoming catalysts
Nab-paclitaxel
Breast Cancer
Symbicort pMDI + budesonide HFA pMDI
Asthma
quetiapine fumarate or valproate
Bipolar Disorder
Docetaxel
Prostate Cancer
Mepolizumab
Eosinophilic Granulomatous Vasculitis
Dapagliflozin 10 mg
Diabetes Mellitus, Non-Insulin-Dependent
Symbicort
COPD Patients
Benralizumab
Asthma
exenatide
Type 2 Diabetes Mellitus
Aclidinium Bromide / Formoterol Fumarate
Chronic Obstructive Pulmonary Disease (COPD)
Aclidinium bromide
Chronic Obstructive Pulmonary Disease (COPD)
MEDI8897
Respiratory Syncytial Virus Infections
Carboplatin
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Saxagliptin, 5 mg + insulin
Type 2 Diabetes
Exenatide (AC2993)
Diabetes Mellitus, Type 2
HFO-1234ze(E)
Mucociliary Clearance
Osimertinib
Lung Cancer
Tiotropium
Chronic Obstructive Pulmonary Disease (COPD)
Terbutaline sulphate
Asthma
Durvalumab
Non-Small Cell Lung Cancer
Budesonide/formoterol (SYMBICORT) pMDI
Chronic Obstructive Pulmonary Disease
ALXN2060
Symptomatic Transthyretin Amyloid Cardiomyopathy
Selumetinib
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Metformin (blinded)
Type 2 Diabetes
Ciclesonide
Perennial Allergic Rhinitis
Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
Chronic Obstructive Pulmonary Disease
Experimental: Tezepelumab
Chronic Rhinosinusitis With Nasal Polyps
Baxdrostat
Resistant Hypertension
TC-5214
Major Depressive Disorder
Tezepelumab
Moderate to Severe Asthma
AZD9833
ER-Positive HER2-Negative Breast Cancer
Benralizumab Arm A
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
formoterol
Asthma
10mg Rosuvastatin
Renal Failure
Dapagliflozin
Heart Failure With Reduced Ejection Fraction (HFrEF)
Saxagliptin
Type 2 Diabetes
Gefitinib (Iressa)
Cancer
MEDI4736
Squamous Cell Carcinoma of the Head and Neck
Metformin
Type 2 Diabetes Mellitus
Candesartan cilexetil
Hypertension
BCG
Non-Muscle- Invasive Bladder Cancer
Durvalumab (MEDI4736)
Non-muscle-invasive Bladder Cancer
exenatide, long acting release
Type 2 Diabetes Mellitus
Pemetrexed
Non-Small Cell Lung Cancer
Fulvestrant
Breast Cancer
Rosuvastatin (Crestor)
Hypercholesterolemia
Paclitaxel
Metastatic Non-small Cell Lung Cancer
Gemcitabine
Biliary Tract Cancer
Quetiapine Fumarate (Seroquel™) drug, mood stabilizer (mood)
Bipolar Disorder
BGF MDI 320/28.8/9.6 μg
Asthma
Tezepelumab (APFS)
Asthma
Sitagliptin
Type 2 Diabetes
BGF MDI HFO 320/14.4/9.6 μg
Chronic Obstructive Pulmonary Disease (COPD)
Datopotamab deruxtecan (Dato-DXd)
Non-small Cell Lung Cancer (NSCLC)
Saxagliptin 5mg
Type 2 Diabetes Mellitus
exenatide once weekly
Type 2 Diabetes Mellitus
Gefitinib, raltitrexed
Colorectal Cancer
Salbutamol
Asthma
Zibotentan/Dapagliflozin
Chronic Kidney Disease With High Proteinuria
ABT-335 plus rosuvastatin
Dyslipidemia
Esomeprazole 20 mg
Gastric Ulcer
Acetylsalicylic acid (ASA)
Acute Ischaemic Stroke
ATACAND
Hypertension
AC2993
Diabetes Mellitus, Type 2
Symbicort Turbuhaler
Bronchial Asthma
rosiglitazone
Diabetes Mellitus, Type 2
Durvalumab plus chemotherapy
Small Cell Lung Carcinoma Extensive Disease
Quetiapine Fumarate Extended- Release
Schizophrenia
Insulin glargine
Type 2 Diabetes Mellitus
AZD5156 (Parent study Sentinel Safety Cohort)
COVID-19, SARS-CoV-2
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level
Hyperkalaemia
5-fluorouracil
Colorectal Cancer
Saxagliptin 2.5 mg
Type 2 Diabetes Mellitus, CKD and Albuminuria
Oxaliplatin
HER2-positive Gastric Cancer
Saxagliptin + Metformin
Diabetes Mellitus, Type 2
Nirsevimab
Respiratory Syncytial Virus Infections
Quetiapine XR
Major Depressive Disorder
budesonide/formoterol (Symbicort)
Asthma
quetiapine fumarate XR
Anxiety
Pulmicort (budesonide) Respules
Asthma
sunitinib
Papillary Renal Cell Carcinoma
D9421-C capsule 3 mg
Crohn's Disease
Capecitabine
Advanced or Metastatic Breast Cancer
Pulmicort Turbuhaler
Asthma
Camizestrant
Advanced Breast Cancer
Cimetidine
Stress Ulcer Prophylaxis
Ticagrelor 60 mg
Diabetes Mellitus, Type 2
Gemcitabine monotherapy
Biliary Tract Cancer
Cisplatin
Muscle Invasive Bladder Cancer
FLOT chemotherapy
Gastrointestinal Neoplasms
Rilvegostomig
Hepatocellular Carcinoma
Daptomycin
Skin Diseases
5-fluorouracil ( in FOLFOX)
Colorectal Cancer
Quetiapine Fumarate Sustained Release
Major Depressive Disorder
Seroquel (quetiapine)
Schizophrenia
Epanova
Hypertriglyceridemia
MEDI4736 (durvalumab)
Non - Small Cell Lung Cancer NSCLC
Intralipid
Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy
exenatide twice daily (BID)
Type 2 Diabetes Mellitus
BGF MDI HFO 320/14.4/9.6μg
COPD (Chronic Obstructive Pulmonary Disease)
Thiazolidinedione (Pioglitazone)
Type 2 Diabetes
Extended release quetiapine (quetiapine XR)
Bipolar Disorder
Palbociclib
Locally Advanced (Inoperable) or Metastatic Breast Cancer
Roxadustat
Anemia
Anastrozole
Breast Cancer
Cisplatin + Gemcitabine
Unresectable Locally Advanced Urothelial Cancer
ABT-143
Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
ZD4054
Prostate Cancer
Rosuvastatin
Hypercholesterolemia
Capivasertib
Triple Negative Breast Neoplasms
corn oil control
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Esomeprazole magnesium (Nexium)
Zollinger-Ellison Syndrome
Dapagliflozin 5 mg
Type 1 Diabetes Mellitus
Conventional Asthma Therapy
Asthma
Pemetrexed/Carboplatin
Non-Small Cell Lung Cancer
pravastatin
Hyperlipoproteinemia Type III
candesartan cilexetil (Atacand)
Hypertension
AZD1222
COVID-19
quetiapine fumarate tablets
Schizophrenia
Durvalumab + SoC chemotherapy
Carcinoma, Non-Small-Cell Lung
ZD1839 (Gefitinib)
Carcinoma
fluticasone/salmeterol (Advair)
Asthma
exemestane
Progression-free Survival
Amitriptyline
Major Depressive Disorder
faslodex 500mg
Hormone Receptor Positive Breast Cancer
Single agent chemotherapy
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Carboplatin+Paclitaxel
Advanced Ovarian Cancer
Olaparib 300mg tablets
Relapsed Ovarian Cancer
Active Comparator: Olaparib tablets
Epithelial Ovarian Cancer
NKTR-118
Opioid-Induced Constipation (OIC)
Osimertinib 80mg/40mg
Non Small Cell Lung Cancer (Stage III)
Zirconium Cyclosilicate
Hyperkalemia
Cediranib
Metastatic Colorectal Cancer
Lomustine Chemotherapy
Recurrent Glioblastoma
Simvastatin
Fredrickson Type IIa & Type IIb Dyslipidaemia
AZD2816
COVID-19
Ezetimibe
Hypercholesterolemia
Rosuvastatin Dose 1
Dyslipidaemia
Roflumilast
Chronic Obstructive Pulmonary Disease (COPD)
Aclidinium Bromide 200 µg
Chronic Obstructive Pulmonary Disease
Budesonide HFA
Asthma
Symbicort pMDI
Asthma
Acalabrutinib
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Bicalutamide
Puberty, Precocious
Seroquel SR
Schizophrenia
Esomeprazole
NSAID Associated Gastric Ulcers
Anifrolumab
Lupus Nephritis
Savolitinib
Carcinoma
Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy
Asthma
Tamoxifen
Quality of Life
pioglitazone
Diabetes
Aclidinium bromide 200 μg bid
Chronic Obstructive Pulmonary Disease (COPD)
Exantide with Dapagliflozin
Diabetes Mellitus
quetiapine fumarate (Seroquel)
Bipolar Disorder
Epoetin alfa
Anemia
Sodium Zirconium Cyclosilicate
Hyperkalemia
AZD5335
Epithelial Ovarian Cancer
divalproex
Bipolar I Disorder
budesonide (Pulmicort)
Asthma
Rosuvastatin calcium
Hypercholesteremia
tralokinumab
Ulcerative Colitis
Zolmitriptan
Migraine
Salmeterol/fluticasone Diskus
Asthma
Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)
Schizophrenia
MEDI3250
Healthy Japanese Children Age 7 Years Through 18 Years
AZD0780
Heterozygous Familial Hypercholesterolaemia
exenatide/insulin glargine
Type 2 Diabetes Mellitus
Candesartan
Congestive Heart Failure
Ranitidine
Gastric Ulcer
Atorvastatin
Coronary Atherosclerosis
lithium
Bipolar I Disorder
metoprolol succinate
Hypertension
Hydrochlorothiazide
Hypertension
Exenatide once weekly suspension
Diabetes Mellitus, Type 2
budesonode bid + terbutaline 'as needed'
Asthma
Olanzapine, risperidone
Schizophrenia
insulin lispro
Type 2 Diabetes Mellitus
Metformin immediate release (IR)
Type 2 Diabetes
Saxagliptin plus metformin IR
Type 2 Diabetes Mellitus
Symbicort TBH - Turbuhaler
Asthma
Olive oil, 4g
Hypertriglyceridemia
Budesonide HFA pMDI
Asthma
Fluticasone
Asthma
Etoposide
Extensive-stage Small Cell Lung Cancer
glipizide
Type 2 Diabetes
Terbutaline Turbuhaler®
Asthma
Esomeprazole Na
Bleeding Peptic Ulcer
Linaclotide
Irritable Bowel Syndrome With Constipation (IBS-C)
Enfortumab Vedotin
Muscle Invasive Bladder Cancer
Budesonide/albuterol metered-dose inhaler 160/180 μg
Asthma, Exercise-Induced
Quetiapine fumarate (Seroquel) SR
Affective Psychosis, Bipolar
(Osimertinib cohort, single-arm, open-label separate cohort)
Carcinoma, Non-Small-Cell Lung
BFF MDI 320/9.6 μg
Asthma
Budesonide/formoterol pMDI
Asthma
NXY-059
Intracerebral Hemorrhage
CRESTOR
Heart Failure
Pertuzumab
Breast Neoplasms
cisplatin + fluorouracil
Esophageal Squamous Cell Carcinoma
Ravulizumab
Thrombotic Microangiopathy
Letrozole
Breast Cancer, Early Breast Cancer
CAEL-101
AL Amyloidosis
AZD7442
COVID-19
Sebelipase alfa (SBC-102)
Lysosomal Acid Lipase Deficiency
Eculizumab
Atypical Hemolytic Uremic Syndrome
Ticagrelor
Acute Coronary Syndrome
Volrustomig
Non-small Cell Lung Cancer
Eculizumab (Soliris®)
Shiga-like Toxin-producing Escherichia Coli
Andexanet
Bleeding
Epanova® (omega-3 carboxylic acids)
Diabetes Mellitus, Type 2
Casdatifan
Advanced Clear Cell Renal Cell Carcinoma
ALXN1850
Hypophosphatasia
ALXN2220
Transthyretin Amyloid Cardiomyopathy
sebelipase alfa
Cholesterol Ester Storage Disease (CESD)
C5 Inhibitor
Paroxysmal Nocturnal Hemoglobinuria
Danicopan
C3 Glomerulonephritis
asfotase alfa
Hypophosphatasia
pexelizumab in conjunction with CABG
Coronary Artery Disease
AZD1152
Acute Myeloid Leukemia
Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Chemotherapy
Anticancer Treatment
Saruparib (AZD5305)
Ovarian Cancer
Esomeprazole IV
Gastrointestinal Hemorrhage
exenatide twice daily
Type 2 Diabetes Mellitus
Ciclesonide nasal
Rhinitis, Allergic, Perennial
fostamatinib
Rheumatoid Arthritis
Benralizumab Arm B
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
D961H capsule 10mg
Reflux Esophagitis
ZD9393 (Zoladex) 10.8 mg
Breast Cancer
Olaparib
Breast Cancer Metastatic
Budesonide/formoterol Turbuhaler
Asthma
ABT-335 and rosuvastatin calcium
Hypercholesterolemia
Omeprazole
Reflux Esophagitis
Formoterol Turbuhaler® 4.5mg
Chronic Obstructive Pulmonary Disease
Quetiapine Fumarate
Bipolar Disorder
Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin
Non-small Cell Lung Cancer
Seroquel®, quetiapine fumarate (atypical antipsychotic)
Bipolar Disorder
cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen
AL Amyloidosis
Baxdrostat/dapagliflozin
Chronic Kidney Disease and Hypertension
Saruparib
Prostate Cancer
Sulphonylurea
Type 2 Diabetes
Datopotamab Deruxtecan
Non-small Cell Lung Cancer
Saxagliptin, Onglyza
Type 2 Diabetes Mellitus
Abiraterone Acetate
Hormone-Sensitive Prostate Cancer
Theophylline
Asthma
Anastrazole (Arimidex)
Breast Cancer
Clopidogrel
Stable Coronary Artery Disease
Acetylsalicylic acid ASA
Acute Coronary Syndrome
Sodium Zirconium Cyclosilicate (ZS) 10g
Hyperkalemia
Oleclumab
Non-Small Cell Lung Cancer
Sodium Zirconium Cyclosilicate (ZS)
Hyperkalemia
Gefitinib
Non-Small Cell Lung Cancer
Tremelimumab
Advanced Hepatocellular Carcinoma
Aclidinium Bromide/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Pramlintide acetate
Diabetes Mellitus, Type 1
Tozorakimab
Chronic Obstructive Pulmonary Disease (COPD)
Quetiapine
Major Depressive Disorder
Glimepiride
Type 2 Diabetes
Medi-546
Systemic Lupus Erythematosus
AZD9291 Dosing
Lung Cancer
budesonide
Asthma
budesonide bid + terbutaline 'as needed'
Asthma
Ciclesonide nasal spray
Hay Fever
AZD4831
Heart Failure With Preserved Ejection Fraction
Seasonal influenza virus vaccine
Asthma
Rosuvastatin 20mg
Homozygous Familial Hypercholesterolemia (HoFH)
Budesonide/Formoterol
Asthma
candsartan cilexetil
Hypertension
Gemcitabine/Cisplatin
Biliary Tract Cancer
Saxagliptin 5 mg
Type 2 Diabetes Mellitus
Nexium 20mg
Erosive Esophagitis
Quetiapine SR
Major Depressive Disorder
Eplontersen
Transthyretin Amyloid Cardiomyopathy
omefas
Severe Hypertriglyceridemia
pexelizumab
Cardio-pulmonary Bypass
Benralizumab (Medi-563)
Asthma
Lithium carbonate
Acute Bipolar Depression
Metformin XR
Type 2 Diabetes
Esomeprazole (D961H) twice daily
Refractory Reflux Esophagitis
Dato-DXd
Breast Cancer
SSRI/Clomipramine
Obsessive Compulsive Disorder
MEDI4736 + Tremelimumab
Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
Escitalopram oxylate
Generalized Anxiety Disorder
AC2993 (exenatide)
Diabetes Mellitus
AZD6234
Obesity/Overweight
MEDI6570
Coronary Heart Disease (CHD)
Tremelimumab monotherapy
Urothelial Bladder Cancer
B - Exenatide 10 mcg twice daily
Diabetes Mellitus, Type 2
AZD5069 50mg
Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD)
ZD1839
Mesothelioma
AZD2693
Nonalcoholic Steatohepatitis
AZD7760
Staphylococcus Aureus
Ramucirumab
Non-Small Cell Lung Cancer
Ticagrelor Dose 1a + Dose 2a
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
AZD4573
Advanced Haematological Malignancies
AZD4818
Chronic Obstructive Pulmonary Disease (COPD)
SBC-103
Mucopolysaccharidosis IIIB
AZD4901 (oral)
Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder
AZD3470
Lymphoma
MEDI7352
Painful Osteoarthritis of the Knee
VKA INR 2-3
Persistent or Permanent Nonvalvular Atrial Fibrillation
AZD1940
Pain
AZD0901
Gastric Cancer
AZD9793 Intravenous (IV) monotherapy
Hepatocellular Carcinoma
Anastrazole
Breast Cancer
AZD8421
ER+ HER2- Advanced Breast Cancer
MEDI0382 low dose
Diabetes Mellitus, Type 2
AZD1446
Adult ADHD
AZD0754
Metastatic Prostate Cancer
AZD2927
Arrhythmia
cediranib and olaparib
Recurrent Platinum Resistant Ovarian Cancer
800 μg AZD7594 once daily
Asthma
AZD0022
Advanced Solid Tumours
MEDI-545
Systemic Lupus Erythematosus
lesogaberan (AZD3355)
Gastroesophageal Reflux Disease
pramlintide acetate 360 mcg
Overweight
AZD0120
Lupus Erythematosus, Systemic
AZD5718
Coronary Artery Disease
AZD5363 when combined with weekly paclitaxel.
Advanced or Metastatic Breast Cancer
ACH-0144471
Paroxysmal Nocturnal Hemoglobinuria
Verinurad 9 mg+Febuxostat 80 mg
Hyperuricemia
ACH-0141625 (Sovaprevir)
Hepatitis C
Tarperprumig
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
AZD1305
Atrial Fibrillation
exenatide (LY2148568)
Type 2 Diabetes Mellitus
Salmeterol
Chronic Obstructive Pulmonary Disease
AZD5069
Asthma
AZD9056
Rheumatoid Arthritis
Casodex
Gynaecomastia
Lenvatinib
Hepatocellular Carcinoma
AZD8683, 50 mcg
Chronic Obstructive Pulmonary Disease (COPD)
AZD5423
Chronic Obstructive Pulmonary Disease (COPD)
AZD9574
Advanced Solid Malignancies
Formoterol fumarate (6 μg)
Chronic Obstructive Pulmonary Disease - COPD
Osimertinib 80 mg/40 mg
Stage II-IIIB Non-small Cell Lung Carcinoma
ZD1839 (IRESSA™)
Head and Neck Cancer
Ticagrelor Tablets
Coronary Artery Disease
Formoterol Fumarate in the Pressair DPI, Low Dose
Asthma
Bertilimumab
Pemphigoid, Bullous
Sebelipase alfa 0.35 mg/kg
Cholesterol Ester Storage Disease(CESD)
Exenatide LAR
Type 2 Diabetes Mellitus
KU-0059436 (AZD2281)(PARP inhibitor)
Ovarian Neoplasm
plevitrexed
Fallopian Tube Cancer
AZD5492
B-cell Malignancies
Part A:AZD8233
Dyslipidemia
AZD1981
Asthma
Montelukast
Asthma
0.5% Roflumilast Cream
Atopic Dermatitis
AZD5851
Hepatocellular Carcinoma
AZD0865
GERD Without Erosive Esophagitis
Verinurad
Chronic Kidney Disease
Atuliflapon
Asthma
AZD8871
Chronic Obstructive Pulmonary Disease
Epanova (4 g) and Lovaza (4 g)
Severe Hypertriglyceridemia
AZD7789
Carcinoma, Non-Small-Cell Lung
AZD2423
Chronic Obstructive Pulmonary Disease
Aclidinium 400 μg / Formoterol 12 μg
Chronic Obstructive Pulmonary Disease
Monalizumab
Non-small Cell Lung Cancer
Ceralasertib
Advanced Solid Tumours
AZD2327
Anxious Major Depressive Disorder
MEDI3506
Atopic Dermatitis
Neoadjuvant Olaparib monotherapy group
Breast Cancer
AC2993 2.5 mcg
Diabetes Mellitus, Non-Insulin-Dependent
ALXN2030
Antibody-Mediated Rejection
AZD3480
ADHD
Biological: AZD3152
COVID-19, SARS-CoV-2
CP-675,206
Malignant Melanoma
GC012F (AZD0120)
Relapsed/ Refractory Multiple Myeloma
AZD8848
Allergic Asthma
AZD9977
Heart Failure
AZD4117
Influenza A
AZD7594 DPI 55μg/50μg.
Asthma
Aclidinium bromide 100 μg bid
Chronic Obstructive Pulmonary Disease (COPD)
AC2592
Congestive Heart Failure
AZD7325
Anxiety Disorders
AZD5462
Chronic Heart Failure
Iressa
Locally Advanced Prostate Cancer
AZD8630
Asthma
AZD2389
Liver Fibrosis
ER tablet 25 mg AZD3241
Parkinson's Disease
AZD9164
Chronic Obstructive Pulmonary Disease
Gefitinib, radiotherapy
Non-Metastatic Prostate Cancer
CP-675,206 and leuprolide acetate and bicalutamide
Prostatic Neoplasms
AZD1656
Type 2 Diabetes Mellitus
AZD2936
Non-Small-Cell Lung Carcinoma
AZD9773 (CytoFab)
Severe Sepsis
AZD2281
Ovarian Neoplasms
80/2.25 μg Symbicort pMDI
Asthma
Cediranib 30 - 90 mg
Cancer
ACH-126,443
Hepatitis B, Chronic
Dacarbazine
Melanoma
AZD9829
Hematological Malignancies
ALXN2420
Acromegaly
ALXN1210
PNH
AZD3427
Pulmonary Hypertension (World Health Organization Group 2)
Anastrozole and goserelin
Breast Cancer
SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
AL Amyloidosis
AZD0171
Locally Advanced or Metastatic Solid Tumours
AZD6765
Treatment Resistant Major Depressive Disorder
Osimertinib + Savolitinib
Non-Small Cell Lung Cancer
Omega-3 carboxylic acid
Non-alcoholic Fatty Liver Disease (NAFLD
terbutaline
Exercise Induced Asthma
Gefitinib and capecitabine
Colorectal Cancer
AZD0486
Chronic Lymphocytic Leukaemia
AZD5004
Diabetes Mellitus, Type 2
LAS100977 0.313 μg
Asthma
AZD9773
Severe Sepsis
Anastrozole (ARIMIDEX™)
Gynecomastia
AB248
Advanced or Metastatic Non-small Cell Lung Cancer
AZD2066
Reflux Episodes
Cotadutide
Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AZD4360
Gastric Cancer
Goserelin acetate
Advanced Breast Cancer
Cerdulatinib
Follicular Lymphoma (FL/Indolent NHL)
AZD1163
Rheumatoid Arthritis
Selumetinib 75 mg
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Lamivudine
HIV Infections
AZD8233
Hyperlipidaemia
AZD3241 300 mg BID
Parkinson's Disease
AZD6750
Melanoma
AZD2171
Metastatic Colorectal Cancer
AS MDI
Asthma
Adavosertib
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
AZD4512
B-cell Non-Hodgkin Lymphoma
Aclidinium/formoterol 400/12μg
Chronic Obstructive Pulmonary Disease (COPD)
AZD2624
Schizophrenia
MEDI4736 monotherapy
Metastatic Pancreatic Ductal Adenocarcinoma
AZD0530
Breast Cancer
AZD9567
Diabetes Mellitus, Type 2
AZD9668
Chronic Obstructive Pulmonary Disease
AZD6621
Prostate Cancer
Abiraterone
Metastatic Castration-resistant Prostate Cancer
AZD8601
Heart Failure
sibutramine
Overweight
Sodium Zirconium Cyclosilicate(ZS)
Hyperkalemia
AZD8931
Neoplasms
AZD6094
Papillary Renal Cell Cancer
AZD5305
Ovarian Cancer
IR (Immediate-Release) quetiapine fumarate (drug)
Schizophrenia
Surovatamig
B-cell Non-Hodgkin Lymphoma
AZD3199
COPD
AC2307
Obesity
AZD5213
Mild Cognitive Impairment
Mitiperstat (AZD4831)
Chronic Obstructive Pulmonary Disease (COPD)
Administration of ceralasertib
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
AZD7798
Crohn's Disease
Insulin
Type 2 Diabetes Mellitus
Elvucitabine
Human Immunodeficiency Virus (HIV)-1 Infection
AZD4017
Raised Intraocular Pressure
Sovaprevir
Hepatitis C, Chronic
AZD8871 100 µg
Chronic Obstructive Pulmonary Disease COPD
Fluorouracil (5-FU)
Gastric Cancer
AZD4604
Asthma
Interferon beta-1a Nebuliser solution 48 μg/mL
Asthma
AZD6244
Non Small Cell Lung Cancer
Vinorelbine
Non-Small Cell Lung Cancer
ALXN1840
Wilson Disease
AS MDI 90 μg
Asthma
FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)
Metastatic Colorectal Cancer
D9421-C, 9mg
Crohn's Disease
RDEA3170
Gout and Hyperuricemia
AZD9550
Overweight and Obesity
CIN-107
Uncontrolled Hypertension
AZD2115
COPD
budesonide/formoterol, 2x 200/6 microgram. 4 times daily
Chronic Obstructive Pulmonary Disease
Cotadutide 100 micrograms
Type 2 Diabetes Mellitus
AZP-3601
Chronic Hypoparathyroidism
600 mg AZD7442 IV
Coronavirus Disease 2019 (COVID-19)
AZD 8529
Schizophrenia
Durvalumab and Tremelimumab
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
AZD7648
Advanced Malignancies
5-flourouracil
Squamous Cell Cancer
Tiotropium 18 μg once-daily
Chronic Obstructive Pulmonary Disease (COPD)
AZD4635
Prostate Cancer
ZD4054 10 mg
Prostatic Neoplasms
Aclidinium 200 μg / formoterol 12 μg
Chronic Obstructive Pulmonary Disease
AZD0837
Nonvalvular Atrial Fibrillation
5-Fluorouracil (5-FU)
Gastroesophageal Adenocarcinoma
Danvatirsen
Non-Small Cell Lung Cancer
Irinotecan
Colorectal Cancer
ALXN1920
Primary Membranous Nephropathy
AZD9291
Advanced Non Small Cell Lung Cancer
Pramlintide and Metreleptin
Obesity
MEDI2070
Crohn's Disease
BMS-512148
Diabetes Mellitus, Type 2
Temozolomide
Melanoma
AZD9150
Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
AZD3355
GERD
AZD8205
Breast Cancer
Leucovorin LV
Endometrial Cancer
gefitinib and fulvestrant
Breast Cancer
ICI35,868 (propofol)
Gastrointestinal Endoscopy
Bis-Choline Tetrathiomolybdate
Wilson Disease
Gefitinib, Cisplatin and Radiotherapy
Cancer of Head and Neck
ALXN2350
BAG3 Mutation Associated Dilated Cardiomyopathy
Ciclesonide/Formoterol Combination
Asthma
Olaparib Continuous (28-Day cycle) 300 mg BD.
Metastatic Triple Negative Breast Cancer
AZD3241
Multiple System Atrophy, MSA
AZD7009, no generic name available
Atrial Fibrillation
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Nab-paclitaxel | Phase 3 | Breast Cancer | - | - |
Symbicort pMDI + budesonide HFA pMDI | Phase 3 | Asthma | - | - |
quetiapine fumarate or valproate | Phase 3 | Bipolar Disorder | - | - |
Docetaxel | Phase 3 | Prostate Cancer | - | - |
Mepolizumab | Phase 3 | Eosinophilic Granulomatous Vasculitis | - | - |
Dapagliflozin 10 mg | Phase 3 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
Symbicort | Phase 3 | COPD Patients | - | - |
Benralizumab | Phase 3 | Asthma | - | - |
exenatide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Aclidinium Bromide / Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Aclidinium bromide | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
MEDI8897 | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
Carboplatin | Phase 3 | Locally Advanced or Metastatic Non-Small Cell Lung Cancer | - | - |
Saxagliptin, 5 mg + insulin | Phase 3 | Type 2 Diabetes | - | - |
Exenatide (AC2993) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
HFO-1234ze(E) | Phase 3 | Mucociliary Clearance | - | - |
Osimertinib | Phase 3 | Lung Cancer | - | - |
Tiotropium | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Terbutaline sulphate | Phase 3 | Asthma | - | - |
Durvalumab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Budesonide/formoterol (SYMBICORT) pMDI | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
ALXN2060 | Phase 3 | Symptomatic Transthyretin Amyloid Cardiomyopathy | - | - |
Selumetinib | Phase 3 | Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV | - | - |
Metformin (blinded) | Phase 3 | Type 2 Diabetes | - | - |
Ciclesonide | Phase 3 | Perennial Allergic Rhinitis | - | - |
Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Experimental: Tezepelumab | Phase 3 | Chronic Rhinosinusitis With Nasal Polyps | - | - |
Baxdrostat | Phase 3 | Resistant Hypertension | - | - |
TC-5214 | Phase 3 | Major Depressive Disorder | - | - |
Tezepelumab | Phase 3 | Moderate to Severe Asthma | - | - |
AZD9833 | Phase 3 | ER-Positive HER2-Negative Breast Cancer | - | - |
Benralizumab Arm A | Phase 3 | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | - | - |
formoterol | Phase 3 | Asthma | - | - |
10mg Rosuvastatin | Phase 3 | Renal Failure | - | - |
Dapagliflozin | Phase 3 | Heart Failure With Reduced Ejection Fraction (HFrEF) | - | - |
Saxagliptin | Phase 3 | Type 2 Diabetes | - | - |
Gefitinib (Iressa) | Phase 3 | Cancer | - | - |
MEDI4736 | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Metformin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Candesartan cilexetil | Phase 3 | Hypertension | - | - |
BCG | Phase 3 | Non-Muscle- Invasive Bladder Cancer | - | - |
Durvalumab (MEDI4736) | Phase 3 | Non-muscle-invasive Bladder Cancer | - | - |
exenatide, long acting release | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Pemetrexed | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Fulvestrant | Phase 3 | Breast Cancer | - | - |
Rosuvastatin (Crestor) | Phase 3 | Hypercholesterolemia | - | - |
Paclitaxel | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
Gemcitabine | Phase 3 | Biliary Tract Cancer | - | - |
Quetiapine Fumarate (Seroquel™) drug, mood stabilizer (mood) | Phase 3 | Bipolar Disorder | - | - |
BGF MDI 320/28.8/9.6 μg | Phase 3 | Asthma | - | - |
Tezepelumab (APFS) | Phase 3 | Asthma | - | - |
Sitagliptin | Phase 3 | Type 2 Diabetes | - | - |
BGF MDI HFO 320/14.4/9.6 μg | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Datopotamab deruxtecan (Dato-DXd) | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
Saxagliptin 5mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
exenatide once weekly | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Gefitinib, raltitrexed | Phase 3 | Colorectal Cancer | - | - |
Salbutamol | Phase 3 | Asthma | - | - |
Zibotentan/Dapagliflozin | Phase 3 | Chronic Kidney Disease With High Proteinuria | - | - |
ABT-335 plus rosuvastatin | Phase 3 | Dyslipidemia | - | - |
Esomeprazole 20 mg | Phase 3 | Gastric Ulcer | - | - |
Acetylsalicylic acid (ASA) | Phase 3 | Acute Ischaemic Stroke | - | - |
ATACAND | Phase 3 | Hypertension | - | - |
AC2993 | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Symbicort Turbuhaler | Phase 3 | Bronchial Asthma | - | - |
rosiglitazone | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Durvalumab plus chemotherapy | Phase 3 | Small Cell Lung Carcinoma Extensive Disease | - | - |
Quetiapine Fumarate Extended- Release | Phase 3 | Schizophrenia | - | - |
Insulin glargine | Phase 3 | Type 2 Diabetes Mellitus | - | - |
AZD5156 (Parent study Sentinel Safety Cohort) | Phase 3 | COVID-19, SARS-CoV-2 | - | - |
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level | Phase 3 | Hyperkalaemia | - | - |
5-fluorouracil | Phase 3 | Colorectal Cancer | - | - |
Saxagliptin 2.5 mg | Phase 3 | Type 2 Diabetes Mellitus, CKD and Albuminuria | - | - |
Oxaliplatin | Phase 3 | HER2-positive Gastric Cancer | - | - |
Saxagliptin + Metformin | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Nirsevimab | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
Quetiapine XR | Phase 3 | Major Depressive Disorder | - | - |
budesonide/formoterol (Symbicort) | Phase 3 | Asthma | - | - |
quetiapine fumarate XR | Phase 3 | Anxiety | - | - |
Pulmicort (budesonide) Respules | Phase 3 | Asthma | - | - |
sunitinib | Phase 3 | Papillary Renal Cell Carcinoma | - | - |
D9421-C capsule 3 mg | Phase 3 | Crohn's Disease | - | - |
Capecitabine | Phase 3 | Advanced or Metastatic Breast Cancer | - | - |
Pulmicort Turbuhaler | Phase 3 | Asthma | - | - |
Camizestrant | Phase 3 | Advanced Breast Cancer | - | - |
Cimetidine | Phase 3 | Stress Ulcer Prophylaxis | - | - |
Ticagrelor 60 mg | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Gemcitabine monotherapy | Phase 3 | Biliary Tract Cancer | - | - |
Cisplatin | Phase 3 | Muscle Invasive Bladder Cancer | - | - |
FLOT chemotherapy | Phase 3 | Gastrointestinal Neoplasms | - | - |
Rilvegostomig | Phase 3 | Hepatocellular Carcinoma | - | - |
Daptomycin | Phase 3 | Skin Diseases | - | - |
5-fluorouracil ( in FOLFOX) | Phase 3 | Colorectal Cancer | - | - |
Quetiapine Fumarate Sustained Release | Phase 3 | Major Depressive Disorder | - | - |
Seroquel (quetiapine) | Phase 3 | Schizophrenia | - | - |
Epanova | Phase 3 | Hypertriglyceridemia | - | - |
MEDI4736 (durvalumab) | Phase 3 | Non - Small Cell Lung Cancer NSCLC | - | - |
Intralipid | Phase 3 | Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy | - | - |
exenatide twice daily (BID) | Phase 3 | Type 2 Diabetes Mellitus | - | - |
BGF MDI HFO 320/14.4/9.6μg | Phase 3 | COPD (Chronic Obstructive Pulmonary Disease) | - | - |
Thiazolidinedione (Pioglitazone) | Phase 3 | Type 2 Diabetes | - | - |
Extended release quetiapine (quetiapine XR) | Phase 3 | Bipolar Disorder | - | - |
Palbociclib | Phase 3 | Locally Advanced (Inoperable) or Metastatic Breast Cancer | - | - |
Roxadustat | Phase 3 | Anemia | - | - |
Anastrozole | Phase 3 | Breast Cancer | - | - |
Cisplatin + Gemcitabine | Phase 3 | Unresectable Locally Advanced Urothelial Cancer | - | - |
ABT-143 | Phase 3 | Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia | - | - |
ZD4054 | Phase 3 | Prostate Cancer | - | - |
Rosuvastatin | Phase 3 | Hypercholesterolemia | - | - |
Capivasertib | Phase 3 | Triple Negative Breast Neoplasms | - | - |
corn oil control | Phase 3 | Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) | - | - |
Esomeprazole magnesium (Nexium) | Phase 3 | Zollinger-Ellison Syndrome | - | - |
Dapagliflozin 5 mg | Phase 3 | Type 1 Diabetes Mellitus | - | - |
Conventional Asthma Therapy | Phase 3 | Asthma | - | - |
Pemetrexed/Carboplatin | Phase 3 | Non-Small Cell Lung Cancer | - | - |
pravastatin | Phase 3 | Hyperlipoproteinemia Type III | - | - |
candesartan cilexetil (Atacand) | Phase 3 | Hypertension | - | - |
AZD1222 | Phase 3 | COVID-19 | - | - |
quetiapine fumarate tablets | Phase 3 | Schizophrenia | - | - |
Durvalumab + SoC chemotherapy | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
ZD1839 (Gefitinib) | Phase 3 | Carcinoma | - | - |
fluticasone/salmeterol (Advair) | Phase 3 | Asthma | - | - |
exemestane | Phase 3 | Progression-free Survival | - | - |
Amitriptyline | Phase 3 | Major Depressive Disorder | - | - |
faslodex 500mg | Phase 3 | Hormone Receptor Positive Breast Cancer | - | - |
Single agent chemotherapy | Phase 3 | Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity | - | - |
Carboplatin+Paclitaxel | Phase 3 | Advanced Ovarian Cancer | - | - |
Olaparib 300mg tablets | Phase 3 | Relapsed Ovarian Cancer | - | - |
Active Comparator: Olaparib tablets | Phase 3 | Epithelial Ovarian Cancer | - | - |
NKTR-118 | Phase 3 | Opioid-Induced Constipation (OIC) | - | - |
Osimertinib 80mg/40mg | Phase 3 | Non Small Cell Lung Cancer (Stage III) | - | - |
Zirconium Cyclosilicate | Phase 3 | Hyperkalemia | - | - |
Cediranib | Phase 3 | Metastatic Colorectal Cancer | - | - |
Lomustine Chemotherapy | Phase 3 | Recurrent Glioblastoma | - | - |
Simvastatin | Phase 3 | Fredrickson Type IIa & Type IIb Dyslipidaemia | - | - |
AZD2816 | Phase 3 | COVID-19 | - | - |
Ezetimibe | Phase 3 | Hypercholesterolemia | - | - |
Rosuvastatin Dose 1 | Phase 3 | Dyslipidaemia | - | - |
Roflumilast | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Aclidinium Bromide 200 µg | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Budesonide HFA | Phase 3 | Asthma | - | - |
Symbicort pMDI | Phase 3 | Asthma | - | - |
Acalabrutinib | Phase 3 | Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | - | - |
Bicalutamide | Phase 3 | Puberty, Precocious | - | - |
Seroquel SR | Phase 3 | Schizophrenia | - | - |
Esomeprazole | Phase 3 | NSAID Associated Gastric Ulcers | - | - |
Anifrolumab | Phase 3 | Lupus Nephritis | - | - |
Savolitinib | Phase 3 | Carcinoma | - | - |
Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy | Phase 3 | Asthma | - | - |
Tamoxifen | Phase 3 | Quality of Life | - | - |
pioglitazone | Phase 3 | Diabetes | - | - |
Aclidinium bromide 200 μg bid | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Exantide with Dapagliflozin | Phase 3 | Diabetes Mellitus | - | - |
quetiapine fumarate (Seroquel) | Phase 3 | Bipolar Disorder | - | - |
Epoetin alfa | Phase 3 | Anemia | - | - |
Sodium Zirconium Cyclosilicate | Phase 3 | Hyperkalemia | - | - |
AZD5335 | Phase 3 | Epithelial Ovarian Cancer | - | - |
divalproex | Phase 3 | Bipolar I Disorder | - | - |
budesonide (Pulmicort) | Phase 3 | Asthma | - | - |
Rosuvastatin calcium | Phase 3 | Hypercholesteremia | - | - |
tralokinumab | Phase 3 | Ulcerative Colitis | - | - |
Zolmitriptan | Phase 3 | Migraine | - | - |
Salmeterol/fluticasone Diskus | Phase 3 | Asthma | - | - |
Quetiapine Fumarate (SEROQUEL) Extended-Release (XR) | Phase 3 | Schizophrenia | - | - |
MEDI3250 | Phase 3 | Healthy Japanese Children Age 7 Years Through 18 Years | - | - |
AZD0780 | Phase 3 | Heterozygous Familial Hypercholesterolaemia | - | - |
exenatide/insulin glargine | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Candesartan | Phase 3 | Congestive Heart Failure | - | - |
Ranitidine | Phase 3 | Gastric Ulcer | - | - |
Atorvastatin | Phase 3 | Coronary Atherosclerosis | - | - |
lithium | Phase 3 | Bipolar I Disorder | - | - |
metoprolol succinate | Phase 3 | Hypertension | - | - |
Hydrochlorothiazide | Phase 3 | Hypertension | - | - |
Exenatide once weekly suspension | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
budesonode bid + terbutaline 'as needed' | Phase 3 | Asthma | - | - |
Olanzapine, risperidone | Phase 3 | Schizophrenia | - | - |
insulin lispro | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Metformin immediate release (IR) | Phase 3 | Type 2 Diabetes | - | - |
Saxagliptin plus metformin IR | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Symbicort TBH - Turbuhaler | Phase 3 | Asthma | - | - |
Olive oil, 4g | Phase 3 | Hypertriglyceridemia | - | - |
Budesonide HFA pMDI | Phase 3 | Asthma | - | - |
Fluticasone | Phase 3 | Asthma | - | - |
Etoposide | Phase 3 | Extensive-stage Small Cell Lung Cancer | - | - |
glipizide | Phase 3 | Type 2 Diabetes | - | - |
Terbutaline Turbuhaler® | Phase 3 | Asthma | - | - |
Esomeprazole Na | Phase 3 | Bleeding Peptic Ulcer | - | - |
Linaclotide | Phase 3 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
Enfortumab Vedotin | Phase 3 | Muscle Invasive Bladder Cancer | - | - |
Budesonide/albuterol metered-dose inhaler 160/180 μg | Phase 3 | Asthma, Exercise-Induced | - | - |
Quetiapine fumarate (Seroquel) SR | Phase 3 | Affective Psychosis, Bipolar | - | - |
(Osimertinib cohort, single-arm, open-label separate cohort) | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
BFF MDI 320/9.6 μg | Phase 3 | Asthma | - | - |
Budesonide/formoterol pMDI | Phase 3 | Asthma | - | - |
NXY-059 | Phase 3 | Intracerebral Hemorrhage | - | - |
CRESTOR | Phase 3 | Heart Failure | - | - |
Pertuzumab | Phase 3 | Breast Neoplasms | - | - |
cisplatin + fluorouracil | Phase 3 | Esophageal Squamous Cell Carcinoma | - | - |
Ravulizumab | Phase 3 | Thrombotic Microangiopathy | - | - |
Letrozole | Phase 3 | Breast Cancer, Early Breast Cancer | - | - |
CAEL-101 | Phase 3 | AL Amyloidosis | - | - |
AZD7442 | Phase 3 | COVID-19 | - | - |
Sebelipase alfa (SBC-102) | Phase 3 | Lysosomal Acid Lipase Deficiency | - | - |
Eculizumab | Phase 3 | Atypical Hemolytic Uremic Syndrome | - | - |
Ticagrelor | Phase 3 | Acute Coronary Syndrome | - | - |
Volrustomig | Phase 3 | Non-small Cell Lung Cancer | - | - |
Eculizumab (Soliris®) | Phase 3 | Shiga-like Toxin-producing Escherichia Coli | - | - |
Andexanet | Phase 3 | Bleeding | - | - |
Epanova® (omega-3 carboxylic acids) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Casdatifan | Phase 3 | Advanced Clear Cell Renal Cell Carcinoma | - | - |
ALXN1850 | Phase 3 | Hypophosphatasia | - | - |
ALXN2220 | Phase 3 | Transthyretin Amyloid Cardiomyopathy | - | - |
sebelipase alfa | Phase 3 | Cholesterol Ester Storage Disease (CESD) | - | - |
C5 Inhibitor | Phase 3 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
Danicopan | Phase 3 | C3 Glomerulonephritis | - | - |
asfotase alfa | Phase 3 | Hypophosphatasia | - | - |
pexelizumab in conjunction with CABG | Phase 3 | Coronary Artery Disease | - | - |
AZD1152 | Phase 3 | Acute Myeloid Leukemia | - | - |
Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Chemotherapy | Phase 3 | Anticancer Treatment | - | - |
Saruparib (AZD5305) | Phase 3 | Ovarian Cancer | - | - |
Esomeprazole IV | Phase 3 | Gastrointestinal Hemorrhage | - | - |
exenatide twice daily | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Ciclesonide nasal | Phase 3 | Rhinitis, Allergic, Perennial | - | - |
fostamatinib | Phase 3 | Rheumatoid Arthritis | - | - |
Benralizumab Arm B | Phase 3 | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | - | - |
D961H capsule 10mg | Phase 3 | Reflux Esophagitis | - | - |
ZD9393 (Zoladex) 10.8 mg | Phase 3 | Breast Cancer | - | - |
Olaparib | Phase 3 | Breast Cancer Metastatic | - | - |
Budesonide/formoterol Turbuhaler | Phase 3 | Asthma | - | - |
ABT-335 and rosuvastatin calcium | Phase 3 | Hypercholesterolemia | - | - |
Omeprazole | Phase 3 | Reflux Esophagitis | - | - |
Formoterol Turbuhaler® 4.5mg | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Quetiapine Fumarate | Phase 3 | Bipolar Disorder | - | - |
Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin | Phase 3 | Non-small Cell Lung Cancer | - | - |
Seroquel®, quetiapine fumarate (atypical antipsychotic) | Phase 3 | Bipolar Disorder | - | - |
cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen | Phase 3 | AL Amyloidosis | - | - |
Baxdrostat/dapagliflozin | Phase 3 | Chronic Kidney Disease and Hypertension | - | - |
Saruparib | Phase 3 | Prostate Cancer | - | - |
Sulphonylurea | Phase 3 | Type 2 Diabetes | - | - |
Datopotamab Deruxtecan | Phase 3 | Non-small Cell Lung Cancer | - | - |
Saxagliptin, Onglyza | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Abiraterone Acetate | Phase 3 | Hormone-Sensitive Prostate Cancer | - | - |
Theophylline | Phase 3 | Asthma | - | - |
Anastrazole (Arimidex) | Phase 3 | Breast Cancer | - | - |
Clopidogrel | Phase 3 | Stable Coronary Artery Disease | - | - |
Acetylsalicylic acid ASA | Phase 3 | Acute Coronary Syndrome | - | - |
Sodium Zirconium Cyclosilicate (ZS) 10g | Phase 3 | Hyperkalemia | - | - |
Oleclumab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Sodium Zirconium Cyclosilicate (ZS) | Phase 3 | Hyperkalemia | - | - |
Gefitinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Tremelimumab | Phase 3 | Advanced Hepatocellular Carcinoma | - | - |
Aclidinium Bromide/Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Pramlintide acetate | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
Tozorakimab | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Quetiapine | Phase 3 | Major Depressive Disorder | - | - |
Glimepiride | Phase 3 | Type 2 Diabetes | - | - |
Medi-546 | Phase 3 | Systemic Lupus Erythematosus | - | - |
AZD9291 Dosing | Phase 3 | Lung Cancer | - | - |
budesonide | Phase 3 | Asthma | - | - |
budesonide bid + terbutaline 'as needed' | Phase 3 | Asthma | - | - |
Ciclesonide nasal spray | Phase 3 | Hay Fever | - | - |
AZD4831 | Phase 3 | Heart Failure With Preserved Ejection Fraction | - | - |
Seasonal influenza virus vaccine | Phase 3 | Asthma | - | - |
Rosuvastatin 20mg | Phase 3 | Homozygous Familial Hypercholesterolemia (HoFH) | - | - |
Budesonide/Formoterol | Phase 3 | Asthma | - | - |
candsartan cilexetil | Phase 3 | Hypertension | - | - |
Gemcitabine/Cisplatin | Phase 3 | Biliary Tract Cancer | - | - |
Saxagliptin 5 mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Nexium 20mg | Phase 3 | Erosive Esophagitis | - | - |
Quetiapine SR | Phase 3 | Major Depressive Disorder | - | - |
Eplontersen | Phase 3 | Transthyretin Amyloid Cardiomyopathy | - | - |
omefas | Phase 3 | Severe Hypertriglyceridemia | - | - |
pexelizumab | Phase 3 | Cardio-pulmonary Bypass | - | - |
Benralizumab (Medi-563) | Phase 3 | Asthma | - | - |
Lithium carbonate | Phase 3 | Acute Bipolar Depression | - | - |
Metformin XR | Phase 3 | Type 2 Diabetes | - | - |
Esomeprazole (D961H) twice daily | Phase 3 | Refractory Reflux Esophagitis | - | - |
Dato-DXd | Phase 3 | Breast Cancer | - | - |
SSRI/Clomipramine | Phase 3 | Obsessive Compulsive Disorder | - | - |
MEDI4736 + Tremelimumab | Phase 3 | Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN | - | - |
Escitalopram oxylate | Phase 3 | Generalized Anxiety Disorder | - | - |
AC2993 (exenatide) | Phase 2 | Diabetes Mellitus | - | - |
AZD6234 | Phase 2 | Obesity/Overweight | - | - |
MEDI6570 | Phase 2 | Coronary Heart Disease (CHD) | - | - |
Tremelimumab monotherapy | Phase 2 | Urothelial Bladder Cancer | - | - |
B - Exenatide 10 mcg twice daily | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
AZD5069 50mg | Phase 2 | Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD) | - | - |
ZD1839 | Phase 2 | Mesothelioma | - | - |
AZD2693 | Phase 2 | Nonalcoholic Steatohepatitis | - | - |
AZD7760 | Phase 2 | Staphylococcus Aureus | - | - |
Ramucirumab | Phase 2 | Non-Small Cell Lung Cancer | - | - |
Ticagrelor Dose 1a + Dose 2a | Phase 2 | Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease | - | - |
AZD4573 | Phase 2 | Advanced Haematological Malignancies | - | - |
AZD4818 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
SBC-103 | Phase 2 | Mucopolysaccharidosis IIIB | - | - |
AZD4901 (oral) | Phase 2 | Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder | - | - |
AZD3470 | Phase 2 | Lymphoma | - | - |
MEDI7352 | Phase 2 | Painful Osteoarthritis of the Knee | - | - |
VKA INR 2-3 | Phase 2 | Persistent or Permanent Nonvalvular Atrial Fibrillation | - | - |
AZD1940 | Phase 2 | Pain | - | - |
AZD0901 | Phase 2 | Gastric Cancer | - | - |
AZD9793 Intravenous (IV) monotherapy | Phase 2 | Hepatocellular Carcinoma | - | - |
Anastrazole | Phase 2 | Breast Cancer | - | - |
AZD8421 | Phase 2 | ER+ HER2- Advanced Breast Cancer | - | - |
MEDI0382 low dose | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
AZD1446 | Phase 2 | Adult ADHD | - | - |
AZD0754 | Phase 2 | Metastatic Prostate Cancer | - | - |
AZD2927 | Phase 2 | Arrhythmia | - | - |
cediranib and olaparib | Phase 2 | Recurrent Platinum Resistant Ovarian Cancer | - | - |
800 μg AZD7594 once daily | Phase 2 | Asthma | - | - |
AZD0022 | Phase 2 | Advanced Solid Tumours | - | - |
MEDI-545 | Phase 2 | Systemic Lupus Erythematosus | - | - |
lesogaberan (AZD3355) | Phase 2 | Gastroesophageal Reflux Disease | - | - |
pramlintide acetate 360 mcg | Phase 2 | Overweight | - | - |
AZD0120 | Phase 2 | Lupus Erythematosus, Systemic | - | - |
AZD5718 | Phase 2 | Coronary Artery Disease | - | - |
AZD5363 when combined with weekly paclitaxel. | Phase 2 | Advanced or Metastatic Breast Cancer | - | - |
ACH-0144471 | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
Verinurad 9 mg+Febuxostat 80 mg | Phase 2 | Hyperuricemia | - | - |
ACH-0141625 (Sovaprevir) | Phase 2 | Hepatitis C | - | - |
Tarperprumig | Phase 2 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | - | - |
AZD1305 | Phase 2 | Atrial Fibrillation | - | - |
exenatide (LY2148568) | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Salmeterol | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD5069 | Phase 2 | Asthma | - | - |
AZD9056 | Phase 2 | Rheumatoid Arthritis | - | - |
Casodex | Phase 2 | Gynaecomastia | - | - |
Lenvatinib | Phase 2 | Hepatocellular Carcinoma | - | - |
AZD8683, 50 mcg | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD5423 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD9574 | Phase 2 | Advanced Solid Malignancies | - | - |
Formoterol fumarate (6 μg) | Phase 2 | Chronic Obstructive Pulmonary Disease - COPD | - | - |
Osimertinib 80 mg/40 mg | Phase 2 | Stage II-IIIB Non-small Cell Lung Carcinoma | - | - |
ZD1839 (IRESSA™) | Phase 2 | Head and Neck Cancer | - | - |
Ticagrelor Tablets | Phase 2 | Coronary Artery Disease | - | - |
Formoterol Fumarate in the Pressair DPI, Low Dose | Phase 2 | Asthma | - | - |
Bertilimumab | Phase 2 | Pemphigoid, Bullous | - | - |
Sebelipase alfa 0.35 mg/kg | Phase 2 | Cholesterol Ester Storage Disease(CESD) | - | - |
Exenatide LAR | Phase 2 | Type 2 Diabetes Mellitus | - | - |
KU-0059436 (AZD2281)(PARP inhibitor) | Phase 2 | Ovarian Neoplasm | - | - |
plevitrexed | Phase 2 | Fallopian Tube Cancer | - | - |
AZD5492 | Phase 2 | B-cell Malignancies | - | - |
Part A:AZD8233 | Phase 2 | Dyslipidemia | - | - |
AZD1981 | Phase 2 | Asthma | - | - |
Montelukast | Phase 2 | Asthma | - | - |
0.5% Roflumilast Cream | Phase 2 | Atopic Dermatitis | - | - |
AZD5851 | Phase 2 | Hepatocellular Carcinoma | - | - |
AZD0865 | Phase 2 | GERD Without Erosive Esophagitis | - | - |
Verinurad | Phase 2 | Chronic Kidney Disease | - | - |
Atuliflapon | Phase 2 | Asthma | - | - |
AZD8871 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Epanova (4 g) and Lovaza (4 g) | Phase 2 | Severe Hypertriglyceridemia | - | - |
AZD7789 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
AZD2423 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Aclidinium 400 μg / Formoterol 12 μg | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Monalizumab | Phase 2 | Non-small Cell Lung Cancer | - | - |
Ceralasertib | Phase 2 | Advanced Solid Tumours | - | - |
AZD2327 | Phase 2 | Anxious Major Depressive Disorder | - | - |
MEDI3506 | Phase 2 | Atopic Dermatitis | - | - |
Neoadjuvant Olaparib monotherapy group | Phase 2 | Breast Cancer | - | - |
AC2993 2.5 mcg | Phase 2 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
ALXN2030 | Phase 2 | Antibody-Mediated Rejection | - | - |
AZD3480 | Phase 2 | ADHD | - | - |
Biological: AZD3152 | Phase 2 | COVID-19, SARS-CoV-2 | - | - |
CP-675,206 | Phase 2 | Malignant Melanoma | - | - |
GC012F (AZD0120) | Phase 2 | Relapsed/ Refractory Multiple Myeloma | - | - |
AZD8848 | Phase 2 | Allergic Asthma | - | - |
AZD9977 | Phase 2 | Heart Failure | - | - |
AZD4117 | Phase 2 | Influenza A | - | - |
AZD7594 DPI 55μg/50μg. | Phase 2 | Asthma | - | - |
Aclidinium bromide 100 μg bid | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AC2592 | Phase 2 | Congestive Heart Failure | - | - |
AZD7325 | Phase 2 | Anxiety Disorders | - | - |
AZD5462 | Phase 2 | Chronic Heart Failure | - | - |
Iressa | Phase 2 | Locally Advanced Prostate Cancer | - | - |
AZD8630 | Phase 2 | Asthma | - | - |
AZD2389 | Phase 2 | Liver Fibrosis | - | - |
ER tablet 25 mg AZD3241 | Phase 2 | Parkinson's Disease | - | - |
AZD9164 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Gefitinib, radiotherapy | Phase 2 | Non-Metastatic Prostate Cancer | - | - |
CP-675,206 and leuprolide acetate and bicalutamide | Phase 2 | Prostatic Neoplasms | - | - |
AZD1656 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
AZD2936 | Phase 2 | Non-Small-Cell Lung Carcinoma | - | - |
AZD9773 (CytoFab) | Phase 2 | Severe Sepsis | - | - |
AZD2281 | Phase 2 | Ovarian Neoplasms | - | - |
80/2.25 μg Symbicort pMDI | Phase 2 | Asthma | - | - |
Cediranib 30 - 90 mg | Phase 2 | Cancer | - | - |
ACH-126,443 | Phase 2 | Hepatitis B, Chronic | - | - |
Dacarbazine | Phase 2 | Melanoma | - | - |
AZD9829 | Phase 2 | Hematological Malignancies | - | - |
ALXN2420 | Phase 2 | Acromegaly | - | - |
ALXN1210 | Phase 2 | PNH | - | - |
AZD3427 | Phase 2 | Pulmonary Hypertension (World Health Organization Group 2) | - | - |
Anastrozole and goserelin | Phase 2 | Breast Cancer | - | - |
SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | Phase 2 | AL Amyloidosis | - | - |
AZD0171 | Phase 2 | Locally Advanced or Metastatic Solid Tumours | - | - |
AZD6765 | Phase 2 | Treatment Resistant Major Depressive Disorder | - | - |
Osimertinib + Savolitinib | Phase 2 | Non-Small Cell Lung Cancer | - | - |
Omega-3 carboxylic acid | Phase 2 | Non-alcoholic Fatty Liver Disease (NAFLD | - | - |
terbutaline | Phase 2 | Exercise Induced Asthma | - | - |
Gefitinib and capecitabine | Phase 2 | Colorectal Cancer | - | - |
AZD0486 | Phase 2 | Chronic Lymphocytic Leukaemia | - | - |
AZD5004 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
LAS100977 0.313 μg | Phase 2 | Asthma | - | - |
AZD9773 | Phase 2 | Severe Sepsis | - | - |
Anastrozole (ARIMIDEX™) | Phase 2 | Gynecomastia | - | - |
AB248 | Phase 2 | Advanced or Metastatic Non-small Cell Lung Cancer | - | - |
AZD2066 | Phase 2 | Reflux Episodes | - | - |
Cotadutide | Phase 2 | Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | - | - |
AZD4360 | Phase 2 | Gastric Cancer | - | - |
Goserelin acetate | Phase 2 | Advanced Breast Cancer | - | - |
Cerdulatinib | Phase 2 | Follicular Lymphoma (FL/Indolent NHL) | - | - |
AZD1163 | Phase 2 | Rheumatoid Arthritis | - | - |
Selumetinib 75 mg | Phase 2 | Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV | - | - |
Lamivudine | Phase 2 | HIV Infections | - | - |
AZD8233 | Phase 2 | Hyperlipidaemia | - | - |
AZD3241 300 mg BID | Phase 2 | Parkinson's Disease | - | - |
AZD6750 | Phase 2 | Melanoma | - | - |
AZD2171 | Phase 2 | Metastatic Colorectal Cancer | - | - |
AS MDI | Phase 2 | Asthma | - | - |
Adavosertib | Phase 2 | Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation | - | - |
AZD4512 | Phase 2 | B-cell Non-Hodgkin Lymphoma | - | - |
Aclidinium/formoterol 400/12μg | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD2624 | Phase 2 | Schizophrenia | - | - |
MEDI4736 monotherapy | Phase 2 | Metastatic Pancreatic Ductal Adenocarcinoma | - | - |
AZD0530 | Phase 2 | Breast Cancer | - | - |
AZD9567 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
AZD9668 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD6621 | Phase 2 | Prostate Cancer | - | - |
Abiraterone | Phase 2 | Metastatic Castration-resistant Prostate Cancer | - | - |
AZD8601 | Phase 2 | Heart Failure | - | - |
sibutramine | Phase 2 | Overweight | - | - |
Sodium Zirconium Cyclosilicate(ZS) | Phase 2 | Hyperkalemia | - | - |
AZD8931 | Phase 2 | Neoplasms | - | - |
AZD6094 | Phase 2 | Papillary Renal Cell Cancer | - | - |
AZD5305 | Phase 2 | Ovarian Cancer | - | - |
IR (Immediate-Release) quetiapine fumarate (drug) | Phase 2 | Schizophrenia | - | - |
Surovatamig | Phase 2 | B-cell Non-Hodgkin Lymphoma | - | - |
AZD3199 | Phase 2 | COPD | - | - |
AC2307 | Phase 2 | Obesity | - | - |
AZD5213 | Phase 2 | Mild Cognitive Impairment | - | - |
Mitiperstat (AZD4831) | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Administration of ceralasertib | Phase 2 | Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer | - | - |
AZD7798 | Phase 2 | Crohn's Disease | - | - |
Insulin | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Elvucitabine | Phase 2 | Human Immunodeficiency Virus (HIV)-1 Infection | - | - |
AZD4017 | Phase 2 | Raised Intraocular Pressure | - | - |
Sovaprevir | Phase 2 | Hepatitis C, Chronic | - | - |
AZD8871 100 µg | Phase 2 | Chronic Obstructive Pulmonary Disease COPD | - | - |
Fluorouracil (5-FU) | Phase 2 | Gastric Cancer | - | - |
AZD4604 | Phase 2 | Asthma | - | - |
Interferon beta-1a Nebuliser solution 48 μg/mL | Phase 2 | Asthma | - | - |
AZD6244 | Phase 2 | Non Small Cell Lung Cancer | - | - |
Vinorelbine | Phase 2 | Non-Small Cell Lung Cancer | - | - |
ALXN1840 | Phase 2 | Wilson Disease | - | - |
AS MDI 90 μg | Phase 2 | Asthma | - | - |
FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan) | Phase 2 | Metastatic Colorectal Cancer | - | - |
D9421-C, 9mg | Phase 2 | Crohn's Disease | - | - |
RDEA3170 | Phase 2 | Gout and Hyperuricemia | - | - |
AZD9550 | Phase 2 | Overweight and Obesity | - | - |
CIN-107 | Phase 2 | Uncontrolled Hypertension | - | - |
AZD2115 | Phase 2 | COPD | - | - |
budesonide/formoterol, 2x 200/6 microgram. 4 times daily | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Cotadutide 100 micrograms | Phase 2 | Type 2 Diabetes Mellitus | - | - |
AZP-3601 | Phase 2 | Chronic Hypoparathyroidism | - | - |
600 mg AZD7442 IV | Phase 2 | Coronavirus Disease 2019 (COVID-19) | - | - |
AZD 8529 | Phase 2 | Schizophrenia | - | - |
Durvalumab and Tremelimumab | Phase 2 | Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma | - | - |
AZD7648 | Phase 2 | Advanced Malignancies | - | - |
5-flourouracil | Phase 2 | Squamous Cell Cancer | - | - |
Tiotropium 18 μg once-daily | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD4635 | Phase 2 | Prostate Cancer | - | - |
ZD4054 10 mg | Phase 2 | Prostatic Neoplasms | - | - |
Aclidinium 200 μg / formoterol 12 μg | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD0837 | Phase 2 | Nonvalvular Atrial Fibrillation | - | - |
5-Fluorouracil (5-FU) | Phase 2 | Gastroesophageal Adenocarcinoma | - | - |
Danvatirsen | Phase 2 | Non-Small Cell Lung Cancer | - | - |
Irinotecan | Phase 2 | Colorectal Cancer | - | - |
ALXN1920 | Phase 2 | Primary Membranous Nephropathy | - | - |
AZD9291 | Phase 2 | Advanced Non Small Cell Lung Cancer | - | - |
Pramlintide and Metreleptin | Phase 2 | Obesity | - | - |
MEDI2070 | Phase 2 | Crohn's Disease | - | - |
BMS-512148 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Temozolomide | Phase 2 | Melanoma | - | - |
AZD9150 | Phase 2 | Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck | - | - |
AZD3355 | Phase 2 | GERD | - | - |
AZD8205 | Phase 2 | Breast Cancer | - | - |
Leucovorin LV | Phase 2 | Endometrial Cancer | - | - |
gefitinib and fulvestrant | Phase 2 | Breast Cancer | - | - |
ICI35,868 (propofol) | Phase 2 | Gastrointestinal Endoscopy | - | - |
Bis-Choline Tetrathiomolybdate | Phase 2 | Wilson Disease | - | - |
Gefitinib, Cisplatin and Radiotherapy | Phase 2 | Cancer of Head and Neck | - | - |
ALXN2350 | Phase 2 | BAG3 Mutation Associated Dilated Cardiomyopathy | - | - |
Ciclesonide/Formoterol Combination | Phase 2 | Asthma | - | - |
Olaparib Continuous (28-Day cycle) 300 mg BD. | Phase 2 | Metastatic Triple Negative Breast Cancer | - | - |
AZD3241 | Phase 2 | Multiple System Atrophy, MSA | - | - |
AZD7009, no generic name available | Phase 2 | Atrial Fibrillation | - | - |
Asthma
1 drug in this indication
Obesity/Overweight
1 drug in this indication
Acute Myeloid Leukemia
1 drug in this indication
Diabetes Mellitus
1 drug in this indication
Coronary Heart Disease (CHD)
1 drug in this indication
Urothelial Bladder Cancer
1 drug in this indication
Diabetes Mellitus, Type 2
1 drug in this indication
Chronic Obstructive Pulmonary Disease
1 drug in this indication
Mesothelioma
1 drug in this indication
Anticancer Treatment
1 drug in this indication
Ovarian Cancer
1 drug in this indication
Gastrointestinal Hemorrhage
1 drug in this indication
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)